Published: 4 March 2021

Publications

Recent approvals: new active ingredients or new indications

Published: 4 March 2021
Prescriber Update 42(1): 11
March 2021

For the period 16 October 2020 to 15 January 2021.

Recent approvals of medicines with new active ingredients

Trade name (active ingredient) Dose form and strength(s) Therapeutic area
Constella (linaclotide) Capsule
72 mcg
145 mcg
290 mcg
Chronic idiopathic constipation
Irritable bowel syndrome
Parizem (paricalcitol) Liquid filled capsule
1 mcg
2 mcg
Secondary hyperparathyroidism
Rinvoq (upadacitinib hemihydrate Modified release tablet
15 mg
Rheumatoid arthritis

Approved medicines with new indications

Trade Name (active ingredient) Dose form and strength(s) New therapeutic area(s)
Dexmethsone (dexamethasone) Tablet
0.5 mg
4 mg
Coronavirus (COVID-19) infection

See the Medsafe website for:

Hide menus
Show menus
0 1 2 4 5 6 7 9 [ /